Pathological Effects of Aflatoxin and Their Amelioration by Vitamin E in White Leghorn Layers

White Leghorn layer breeder hens, 30 weeks of age, were divided into 12 groups (A-L). Group A was kept on basal feed and served as control, while group B was offered feed supplemented with vitamin E (100 mg/Kg). Groups C-G were offered feed containing 100, 500, 2,500, 5,000 and 10,000 µg/Kg aflatoxin B1 (AFB1), respectively, whereas groups H-L were offered same dietary levels of AFB1 along with vitamin E (100 mg/Kg). The experimental feeds were offered for three weeks and afterward all the groups were switched over to basal feed for next two weeks. Body weight, absolute and relative weights of liver and kidneys of AF fed birds were significantly higher than control group. Pathological lesions in aflatoxin (AF) fed birds included enlarged, pale and friable liver, swollen kidneys and hemorrhages on different organs. Histopathological lesions in liver included fatty change, congestion and hemorrhages, while in kidneys tubular necrosis, cellular infiltration, congestion and hemorrhages were found in groups fed AFB1 at 500 μg/Kg and higher doses. In AF fed hens, no significant ameliorative effects of vitamin E could be observed upon AF induced decrease in feed intake, gross pathology and histopathological alterations and organ weight except body weights. It was concluded that the vitamin E ameliorated the AFB1 induced toxic effects in some of parameters studied

Disposition Kinetics and Optimal Dosage of Ciprofloxacin in Healthy Domestic Ruminant Species

The purpose of this experimental study was to determine the disposition kinetics and optimal dosages of ciprofloxacin in healthy domestic ruminant species including adult female buffalo, cow, sheep and goat. The drug was given as a single intramuscular dose of 5 mg/kg. The plasma concentrations of the drug were determined with HPLC and pharmacokinetic variables were determined. The biological half-life (t1/2 β was longer in cows (3.25 ± 0.46 h) followed by intermediate values in buffaloes (3.05 ± 0.20 h) and sheep (2.93 ± 0.45 h) and shorter in goats (2.62 ± 0.39 h). The volume of distribution (Vd) in buffaloes was 1.09 ± 0.06 l/kg, cows 1.24 ± 0.16 l/kg, sheep 2.89 ± 0.30 l/kg and goats 3.76 ± 0.92 l/kg. Total body clearance (ClB) expressed in l/h/kg was minimum in buffaloes 0.25 ± 0.02 followed by values in cows 0.31 ± 0.02 and sheep 0.75 ± 0.04 and maximum in goats 1.09 ± 0.11. An optimal dosage regimen for 12-h interval consisted of 5.17, 5.62, 6.54 and 6.10 mg/kg body weight as priming and 4.84, 5.37, 6.26 and 5.91 mg/kg body weight as maintenance intramuscular dose in buffalo, cow, sheep and goat, respectively. The manufacturers of ciprofloxacin have claimed 5 mg/kg dose to be repeated after 24 h. However, the investigated dosage regimen may be repeated after 12 h to maintain MIC at the end of the dosage interval. Therefore, it is imperative that an optimal dosage regimen be based on the disposition kinetics data determined in the species and environment in which a drug is to be employed clinically

Pathological Responses of White Leghorn Breeder Hens Kept on Ochratoxin A Contaminated Feed

Mycotoxins are among the most important environmental contaminants. In the present study, ochratoxin A (OTA) was produced by propagation of Aspergillus ochraceus and fed to breeder hens. For this purpose, 84 breeder hens were divided into seven groups (A-G). Group A served as control, while groups B, C, D, E, F and G were fed OTA at 0.1, 0.5, 1.0, 3.0, 5.0 and 10.0 mg/Kg feed, respectively for 3 weeks. Clinical signs, feed intake, feed conversion ratio and egg mass production were recorded on daily basis, while body weight was recorded on weekly basis. Lesions on visceral organs and serum biochemical parameters were determined. Significant decrease in feed intake, body weight and egg mass production was found in the OTA treated groups compared to control (P<0.05). Among different groups, diarrhea, unthriftiness, water intake and depression increased with increase in dietary OTA levels. Enlargement and hemorrhages on liver and kidney were more severe in birds fed higher dietary OTA levels. Serum ALT, urea, creatinine and total protein levels were significantly higher in OTA treated groups. It was concluded that production performance, pathological alterations and serum biochemical changes determined became more severe with increase in dietary levels of OTA

Delayed colorectal cancer care during covid-19 pandemic (decor-19). Global perspective from an international survey

Background The widespread nature of coronavirus disease 2019 (COVID-19) has been unprecedented. We sought to analyze its global impact with a survey on colorectal cancer (CRC) care during the pandemic. Methods The impact of COVID-19 on preoperative assessment, elective surgery, and postoperative management of CRC patients was explored by a 35-item survey, which was distributed worldwide to members of surgical societies with an interest in CRC care. Respondents were divided into two comparator groups: 1) ‘delay’ group: CRC care affected by the pandemic; 2) ‘no delay’ group: unaltered CRC practice. Results A total of 1,051 respondents from 84 countries completed the survey. No substantial differences in demographics were found between the ‘delay’ (745, 70.9%) and ‘no delay’ (306, 29.1%) groups. Suspension of multidisciplinary team meetings, staff members quarantined or relocated to COVID-19 units, units fully dedicated to COVID-19 care, personal protective equipment not readily available were factors significantly associated to delays in endoscopy, radiology, surgery, histopathology and prolonged chemoradiation therapy-to-surgery intervals. In the ‘delay’ group, 48.9% of respondents reported a change in the initial surgical plan and 26.3% reported a shift from elective to urgent operations. Recovery of CRC care was associated with the status of the outbreak. Practicing in COVID-free units, no change in operative slots and staff members not relocated to COVID-19 units were statistically associated with unaltered CRC care in the ‘no delay’ group, while the geographical distribution was not. Conclusions Global changes in diagnostic and therapeutic CRC practices were evident. Changes were associated with differences in health-care delivery systems, hospital’s preparedness, resources availability, and local COVID-19 prevalence rather than geographical factors. Strategic planning is required to optimize CRC care